(4.5 to 7.0mm), the mean common iliac artery (CIA) size was 28mm (20 to 43mm). All patients received follow-up exams with mean follow-up 2.5 years. Bilateral CIA was present in 80% (16/20) of patients. Technical success was 100% with no procedure related complications. All aneurysms were treated successfully. The mean implantation time was 52+24 minutes (range, 35 to 98 minutes). There was no perioperative mortality. No internal iliac arteries were lost acutely or occluded during follow-up. There were no ruptures or conversions in this cohort group. Two patients required secondary interventions.
The purpose of this study is to investigate the advantage of DES for FP lesions in diabetic patients.
METHODS This is a single center, retrospective study. Between July 2008 and April 2013, 74 lesions in 58 diabetic patients were treated with bare metal stents (BMS group).52 lesions in 42 diabetic patients were treated with Zilver PTX paclitaxel-eluting nitinol stents (DES group). We evaluate the clinical outcomes as primary patency, freedom from re-occlusion, major adverse limb events (MALE) and allcause death after endovascular therapy. Stent patency was assessed by either duplex ultrasound or angiography. 
RESULTS

